Life Sciences

Congress investigating Bayer advertising claims

Pharma Compliance Alert, October 22, 2008

Representatives John Dingell (D-MI) and Bart Stupak (D-MI) continue to examine pharmaceutical direct-to-consumer advertising, this time taking aim at Bayer Aspirin with Heart Advantage.

Post a Comment

Name:

 

E-mail:

 

Please enter your comment below:

   

Please enter the text below:

   
   
    Healthcare Life Safety Compliance
  • Healthcare Life Safety Compliance

    Created exclusively for healthcare facility managers, plant operations professionals, and directors of engineering, this...

  • ePharm5 InDepth

    EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...

  • Medical Environment Update

    A subscription to Medical Environment Update pays for itself by saving you time sorting through complex regulations and...

  • Bloodborne Pathogens Training Video

    Meets OSHA requirements for training employees on the bloodborne pathogens standard!

  • Complete Guide to Lab Safety, 3rd Ed.

    The third edition of this popular resource makes training and compliance easier by consolidating regulations from all...

Most Popular